2,6-Dihydroxyanthracene-9,10-dione, 95.0%, 5g

2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol, 98%, 1g

Pyrazolo[1,5-a]pyridine-6-carboxylic acid, 98%, 1g

2,3-Difluoro-5-nitropyridine, 95.0%, 25g

6-Amino-4-hydroxy-2-mercaptopyrimidine, 95.0%, 1g

tert-Butyl 2-((4R,6S)-6-((E)-2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate, 97%, 25g

CYHALOFOP, 98.0%, 250mg

N-[-4-(2-Bromoethoxy)phenyl]acetamide, 500mg

Ethyl 2-chloro-4-iodobenzoate, 98.0%, 250mg

2,2-DIMETHYL-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 97.0%, 1g

Imidazo[1,2-a]pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]-, 10mg

3-(Piperazin-1-yl)benzo[d]isothiazole hydrochloride, 95.0%, 100g

(+/-)-Thalidomide>98.0%(HPLC)(N)5g